The FDA has issued an early alert for certain Abbott Diabetes Care sensors over incorrect glucose readings, which have been linked to serious injuries and deaths. The Dec. 2 alert applies to about 3 ...

WASHINGTON — Malfunctioning glucose sensors used by millions of people with diabetes have been tied to more than 700 serious injuries and seven deaths worldwide, according to new information released ...

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (DXCM) (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over ...

Abbot has issued a medical device correction for some of its glucose sensor products after identifying a manufacturing issue that can lead to falsely low glucose readings. The correction affects about ...

Incorrect low glucose readings from some Abbott continuous glucose monitoring (CGM) sensors have been potentially linked to 736 severe adverse events and seven deaths globally. Abbott reported this ...

The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the age of 18 with diabetes will ...

San Diego-based Dexcom, a maker of continuous glucose monitors, has filed for a patent for a system that would integrate a smartphone with a Dexcom device, detailing some of the features such a device ...

I used to drive all around northern and southern California, and my reaction to my car's check engine light was typically, "I need to look into that," followed by...not looking into that. This was ...

(RTTNews) - DexCom, Inc. (DXCM) on Wednesday announced that the U.S. Food and Drug Administration (FDA) has cleared Dexcom Smart Basal, the first and only continuous glucose monitor (CGM)-integrated ...